Drug Trial Radar · NCT07247084
A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)
Last checked: Nov 20, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
3,000
Planned (sponsor's estimate)
Start
Nov 24, 2025
Primary completion
Jul 2029
Study completion Jul 2032
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Nov 25, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate tirzepatide within a real-world setting to assess body weight loss and incidence of type 2 diabetes in adults without diabetes who have obesity and at least one weight-related comorbid condition. Eligible participants must be registered patients at a participating site. Participation in the study will last about 260 weeks.
Conditions
- Obesity
Interventions
TirzepatideDrug
Administered SC
Standard of CareOther
Standard of care
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change from Baseline in Body WeightTime frame: Baseline, 24 months
Locations
30 sites in 1 country. Site status is shown where the registry gives one.
P91604 St John's Medical Centre
Altrincham, United Kingdom · Not yet recruiting
P89008 Ashton Medical Group
Ashton-under-Lyne, United Kingdom · Recruiting
Y02319 SSP Bolton General Practice
Bolton, United Kingdom · Not yet recruiting
P83012 Tower Family Healthcare
Bury, United Kingdom · Not yet recruiting
P91014 Washway Road Medical Centre
Cheshire, United Kingdom · Not yet recruiting
P88007 Cheadle Hulme Medical Group (was Cheadle Hulme Health Centre) (Bridge House)
Cheshire, United Kingdom · Not yet recruiting
Y02790 SSP Bolton Medical Centre
Great Lever, United Kingdom · Not yet recruiting
P89002 The Brooke Surgery
Hyde SK14, United Kingdom · Recruiting
P84035 Bodey Medical Centre
Manchester, United Kingdom · Recruiting
P84630 The Arch Medical Practice
Manchester, United Kingdom · Recruiting
P84678 Didsbury Medical Centre
Manchester, United Kingdom · Not yet recruiting
P84017 Ladybarn Group Practice
Manchester, United Kingdom · Not yet recruiting
P84068 Chorlton Family Practice
Manchester, United Kingdom · Not yet recruiting
P84012 Northenden Group Practice
Manchester, United Kingdom · Not yet recruiting
P86004 Peterloo Medical Centre
Manchester, United Kingdom · Recruiting
P83025 St Gabriels Medical Centre
Manchester, United Kingdom · Not yet recruiting
P87019 Silverdale Medical Practice
Manchester, United Kingdom · Recruiting
P91006 Urmston Group Practice
Manchester, United Kingdom · Not yet recruiting
P92620 SSP Ince Surgery (Lower Ince)
Manchester, United Kingdom · Not yet recruiting
P84034 Barlow Medical Centre
Manchester, United Kingdom · Not yet recruiting
P85010 Woodlands Medical Practice
Oldham, United Kingdom · Recruiting
P85011 CH Medical Practice
Oldham, United Kingdom · Recruiting
P86022 Stonefield Street Surgery
Rochdale, United Kingdom · Recruiting
P91021 Firsway Health Centre
Sale, United Kingdom · Not yet recruiting
P91013 Boundary House Medical Centre
Sale, United Kingdom · Not yet recruiting
P87027 Langworthy Medical Practice
Salford, United Kingdom · Recruiting
P88632 Stockport Medical Group
Stockport, United Kingdom · Not yet recruiting
P87016 The Sides Medical Centre
Swinton, United Kingdom · Recruiting
P87025 The Lakes Medical Practice
Swinton, United Kingdom · Recruiting
Y02322 SSP Leigh Family Practice
Wigen, United Kingdom · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.